Abnormal cardiac enzymes in systemic sclerosis: A report of four patients and review of the literature

Clinical Rheumatology

Volumn 33, Issue 3, 2014, Pages 435-438

  Vasta, B ^a   Flower, V ^a   Bucciarelli Ducci, C ^b   Brown, S ^a   Korendowych, E ^a   McHugh, N J ^a,c   Pauling, J D ^a  

^a ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF BATH   (United Kingdom)

Author keywords

Biomarkers; Cardiac MRI; Heart; Immunosuppression; Systemic Sclerosis; Troponin

Indexed keywords

ANTINUCLEAR ANTIBODY; BIOLOGICAL MARKER; BISOPROLOL; CENTROMERE ANTIBODY; CREATINE KINASE; CYCLOPHOSPHAMIDE; DIURETIC AGENT; ILOPROST; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAMIPRIL; TRANSFER FACTOR; TROPONIN T;

ADULT; AGED; CARDIOMEGALY; CARDIOVASCULAR MAGNETIC RESONANCE; CASE REPORT; CAUCASIAN; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CREATINE KINASE BLOOD LEVEL; DIASTOLIC DYSFUNCTION; DISEASE COURSE; DRUG DOSE REDUCTION; DYSPNEA; ELECTROCARDIOGRAM; FATIGUE; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE CONDUCTION; HEART VENTRICLE FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIMITED SCLERODERMA; LUNG ARTERY PRESSURE; LUNG EDEMA; LUNG FUNCTION TEST; MAINTENANCE THERAPY; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE WEAKNESS; MYALGIA; MYOCARDIAL DISEASE; PERICARDIAL EFFUSION; PRESYNCOPE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; SCLERODERMA; SYSTEMIC SCLEROSIS; T WAVE; THORAX PAIN; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT RESPONSE;

ADULT; AGED; FEMALE; HEART; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; SCLERODERMA, SYSTEMIC; TROPONIN T;

EID: 84896450529     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2405-1     Document Type: Review

References (19)

1. Eisenberg M, Nguyen BY, Karnath B (2008) Clinical features of systemic sclerosis. Hospital Physician 33-38
2. Weiss SS, Warren E (1943) Scleroderma heart disease, with a consideration of certain other visceral manifestations of scleroderma. Arch Intern Med 71(6):749-776
3. Champion HC (2008) The heart in scleroderma. Rheum Dis Clin North Am 34(1):181-190
4. PiperWN, Helwig EB (1955) Progressive systemic sclerosis: visceral manifestations of generalized scleroderma. AMA Arch Derm 72(6):535-546
5. Medsger TA Jr, Masi AT (1973) Survival with scleroderma. II.A life-table analysis of clinical and demographic factors in 358 male US veteran patients. J ChronicDis 26(10):647-660
6. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB et al (2005) Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 118(1):2-10 (Pubitemid 40082450)
7. Tyndall AJ, Bannert B, VonkM et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69(10):1809-1815
8. Katus HA (2008) Development of the cardiac troponin T immunoassay. Clin Chem 54(9):1576-1577
9. Badsha H, Gunes B, Grossman J et al (1997) Troponin I assessment of cardiac involvement in patients with connective tissue disease and an elevated creatine kinase MB isoform report of four cases and review of the literature. J Clin Rheumatol 3(3):131-134 (Pubitemid 27278810)
10. Montagnana M, Lippi G, Volpe A et al (2006) Evaluation of cardiac laboratory markers in patients with systemic sclerosis. Clin Biochem 39(9):913-917 (Pubitemid 44363080)
11. Gaal J, Hegedus I, Dévényi K et al (1995) Myocardial gallium-67 citrate scintigraphy in patients with systemic sclerosis. Ann Rheum Dis 54(10):856-858
12. Smaldone C, Pieroni M, De Santis M et al (2010) Biopsy proven active myocarditis in Systemic Sclerosis patients with recent onset cardiac involvement. J Am Coll Cardiol 55(10)
13. Clements PJ, Lachenbruch PA, Seibold JR et al (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20(11):1892-1896 (Pubitemid 24031593)
14. Dinser R, FrerixM, Meier FM et al (2013) Endocardial and myocardial involvement in systemic sclerosis - is there a relevant inflammatory component? Joint Bone Spine 80(3):320-323
15. Allanore Y, Meune C (2010) Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin. Clin Exp Rheumatol 28(5 Suppl 62):S48-S53
16. Belloli L, Carlo-Stella N, Ciocia G et al (2008) Myocardial involvement in systemic sclerosis. Rheumatology 47(7):1070-1072 (Pubitemid 351865936)
17. Kahan A, Allanore Y (2006) Primary myocardial involvement in systemic sclerosis. Rheumatology 45(suppl 4):iv14-17. (Pubitemid 44446757)
18. Hachulla AL, Launay D, Gaxotte V et al (2009) Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 68(12):1878-1884
19. Tzelepis GE, Kelekis N, Plastiras SC et al (2007) Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 56(11):3827-3836 (Pubitemid 350100715)